XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Net Income/(Loss) and Comprehensive Income/(Loss) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Revenue, net $ 10,951   $ 16,334  
OPERATING COSTS AND EXPENSES        
Cost of goods sold 200   293  
Royalties 210   210  
Research and development 19,778 $ 30,059 41,357 $ 48,681
Selling, general, and administrative 13,475 10,393 25,445 18,519
Total operating costs and expenses 33,663 40,452 67,305 67,200
Loss from operations (22,712) (40,452) (50,971) (67,200)
OTHER INCOME, NET        
Gain from sale of priority review voucher, net     62,010  
Interest and other income / (loss) (225) 59 (563) 628
NET INCOME / (LOSS) (22,937) (40,393) 10,476 (66,572)
Other comprehensive income / (loss)        
Foreign currency translation 78 (91) 513 (66)
COMPREHENSIVE INCOME / (LOSS) $ (22,859) $ (40,484) $ 10,989 $ (66,638)
Net income/(loss) per share attributable to common stockholders, basic (in dollars per share) $ (0.53) $ (1.01) $ 0.25 $ (1.67)
Weighted average common shares outstanding, basic (in shares) 43,569,482 39,972,174 42,724,813 39,862,878
Net income/(loss) per share attributable to common stockholders, diluted (in dollars per share) $ (0.53) $ (1.01) $ 0.23 $ (1.67)
Weighted average common shares outstanding, diluted (in shares) 43,569,482 39,972,174 45,080,419 39,862,878
Product        
Revenue, net $ 8,951 $ 0 $ 14,334 $ 0
License        
Revenue, net $ 2,000   $ 2,000